DSpace Repository

The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)